This site uses cookies. By continuing to browse the site without disabling them, you consent to our use of cookies. To learn more about the types of cookies we use, please view our cookie policy.

Indivior -
  • Product Query or Adverse Event
  • Careers
  • Contact Us
  • Locations
  • International
  • About
    • History
    • Executive Committee
    • The Board
    • Grants
  • Diseases of Addiction
    • A Worldwide Crisis
    • The Patient Journey
  • R & D
    • Publications
    • White Papers
    • Sponsored Supplements
  • Products
  • Investors
  • Media
  • Investor Information
    • Annual Reports
    • Latest News
    • RNS Filings
    • RNS Filings (Inside Information)
    • SEC Filings
    • Corporate Alert Service
    • Webcasts / Audiocasts / Presentations
    • Prospectus
    • Upcoming Events
    • Buprenorphine Market Modeling Methodology
  • Share Price Information
    • Share Price Center
    • Share Price Table
    • Historic Share Price
    • Share Price Calculator
    • Demerger: Base Cost
  • Corporate Governance
    • UK Corporate Governance Code
    • Leadership
    • The Board
    • Board Committees
    • Executive Committees
    • Risk Management and Internal Control
    • Directors’ Remuneration Disclosures
    • Indivior Corporate Compliance Program
    • Corporate Responsibility
  • Shareholder Information
    • Managing Your Shareholding
    • Dividends
    • Annual General Meeting
    • American Depositary Receipts
  • Contact Us
  • Investors
  • Investor Information
    • Annual Reports
    • Press Releases
    • RNS Filings
    • RNS Filings (Inside Information)
    • SEC Filings
    • Corporate Alert Service
    • Webcasts / Audiocasts / Presentations
    • Prospectus
    • Upcoming Events
    • Buprenorphine Market Modeling Methodology
  • Share Price Information
    • Share Price Center
    • Share Price Table
    • Historic Share Price
    • Share Price Calculator
    • Demerger: Base Cost
  • Corporate Governance
    • UK Corporate Governance Code
    • Leadership
    • The Board
    • Board Committees
    • Executive Committees
    • Risk Management and Internal Control
    • Directors’ Remuneration Disclosures
    • Corporate Compliance
    • Corporate Responsibility
  • Shareholder Information
    • Managing Your Shareholding
    • Dividends
    • Annual General Meeting
    • American Depositary Receipts
  • Contact Us

Webcasts / Audiocasts / Presentations

Get to know Indivior through past and current webcasts, audiocasts, and presentations.

Webcast: Shaun Thaxter, CEO of Indivior PLC presented at the JP Morgan Healthcare Conference in San Francisco on Wednesday, January 13th

Presentation: Shaun Thaxter, CEO of Indivior PLC presented at the JP Morgan Healthcare Conference in San Francisco on January 13, 2016

Indivior 2016 Financial Outlook Presentation

Indivior R&D Day

Shaun Thaxter presented at the Jefferies London Healthcare Conference on Wednesday 18th November at 9:20am (UK time)

Audiocast Event: Indivior Q3 2015 Results – November 3, 2015

Webcast Event: Indivior H1 2015 Results – July 29, 2015

Presentation: Shaun Thaxter, CEO Indivior PLC, presented at the Jefferies 2015 Global Healthcare Conference in New York City

Webcast Event: Indivior Q1 2015 Results – May 5, 2015

Indivior PLC Preliminary Results for Financial Year 2014

« Previous Page
Next Page »
  • About
  • Diseases of Addiction
  • Products
  • R & D
  • Investors
  • Media
  • MODERN SLAVERY STATEMENT (PDF)
  • Product Query or Adverse Event
  • Careers
  • Contact
  • Terms of Use
  • Privacy Policy
  • International
  • Employee Login

© 2017 Indivior PLC | This site is intended for US audiences. | INDIVIOR is a registered trademark of Indivior UK Limited.

You are now leaving Indivior.com to visit Suboxone.com a US product site intended for US residents and healthcare professionals.

Continue    Return

You are now leaving Indivior.com.

Continue    Return